[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"respiratory-syncytial-virus-rsv-infection\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:respiratory-syncytial-virus-rsv-infection":23},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,61],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":21,"conditions":22,"keywords":28,"overallStatus":48,"whyStopped":4,"lastUpdateSubmitDate":49,"lastUpdatePostDateStruct":50,"startDateStruct":53,"completionDateStruct":55,"leadSponsor":57,"locationsCount":60},"100594116","assessing-the-burden-of-respiratory-syncytial-virus-rsv-100594116",false,"NCT07015255","Assessing the Burden of Respiratory Syncytial Virus (RSV)","Assessing the Burden of Respiratory Syncytial Virus (RSV): the Assessment of the Burden of Respiratory Syncytial Virus (RSV) Across Different Age Groups and Risk Factors","Inclusion Criteria:\n\n* Patients of all ages with a confirmed diagnosis of RSV infection\n* Patients admitted to a SEHA hospital or healthcare facility between January 2018 and December 2024\n* Patients with documented data in the SEHA electronic medical record (EMR) system\n\nExclusion Criteria:\n\n* Patients with suspected RSV infection that is not laboratory-confirmed\n* Patients without sufficient data in the SEHA EMR system","ALL",{"count":18,"type":19},1500,"ESTIMATED","OBSERVATIONAL","This study examines the impact of Respiratory Syncytial Virus (RSV) on people of all ages, from infants to the elderly. It uses hospital records collected between January 2018 and December 2024 to understand:\n\n* How often does RSV occur\n* Who is most at risk\n* The long-term and financial effects of RSV",[23,24,25,26,27],"Respiratory Syncytial Virus (RSV) Infection","Acute Lower Respiratory Tract Infections","Bronchiolitis","Pneumonia","Chronic Respiratory Conditions",[29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,25,26,45,46,47],"Respiratory Syncytial Virus","RSV","RSV Infection","RSV in Infants","RSV in Adults","RSV Hospitalization","RSV Epidemiology","RSV Burden","RSV Risk Factors","Retrospective Study","Observational Study","ICU Admissions","RSV Mortality","RSV Cost Analysis","RSV Complications","Asthma and RSV","Recurrent Wheezing","RSV Surveillance","RSV-Related Comorbidities","NOT_YET_RECRUITING","2025-06-17",{"date":51,"type":52},"2025-06-19","ACTUAL",{"date":54,"type":19},"2025-06",{"date":56,"type":19},"2026-06",{"name":58,"class":59},"Abu Dhabi Health Services Company","OTHER_GOV",1,{"id":62,"slug":63,"hasResults":11,"nctId":64,"briefTitle":65,"officialTitle":65,"acronym":66,"eligibilityCriteria":67,"healthyVolunteers":68,"sex":16,"minAge":69,"maxAge":70,"enrollmentInfo":71,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":73,"conditions":74,"keywords":4,"overallStatus":77,"whyStopped":4,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":81,"completionDateStruct":83,"leadSponsor":85,"locationsCount":60},"100592808","in-depth-analysis-of-the-immune-responses-in-the-upper-respiratory-tract-in-older-adults-infected-or-colonized-with-streptococcus-pneumoniae-spn-100592808","NCT06998251","In-depth Analysis of the Immune Responses in the Upper Respiratory Tract in Older Adults Infected or Colonized With Streptococcus Pneumoniae (Spn)","NoseSpnElderly","Inclusion criteria:\n\n* Aged 60-85 years\n* Able to provide informed consent either independently or by a legal representative\n* Group 1 (Spn pneumonia patients): clinical and\u002For radiological signs of pneumonia\n* Group 1 (Spn pneumonia patients): positive Spn urinary antigen and\u002For blood culture and\u002For positive sputum test.\n* Group 2 (viral respiratory infection patients): clinical signs of a respiratory infection\n* Group 2 (viral respiratory infection patients): positive test for influenza or RSV\n* Group 3 (asymptomatic Spn-carriers): healthy without clinical signs of infection and no lower respiratory symptoms within the last month.\n\nExclusion criteria:\n\n* Immunosuppression,\n* Use of inhalation and\u002For nasal steroids the last month\n* Intubation or under invasive mechanical ventilation\n* Long-term antibiotic treatment prior to disease onset",true,"60 Years","85 Years",{"count":72,"type":19},280,"The NoseSpn-Elderly study aims at characterizing the immune response in the upper respiratory tract in adults aged 60 and over diagnosed with a pneumonia due to a Streptococcus pneumoniae (Spn) infection. The immune response during the acute phase of the infection and after recovery will be compared to the immune response of asymptomatic Spn carriers as well as to the immune response of patients diagnosed with a viral respiratory infection (flu or respiratory syncytial virus (RSV)).\n\nThe primary objective of this observational study is to quantify the inflammatory response in the nasal cavity and to correlate it with bacterial\u002Fviral load and with clinical parameters. The study also aims to compare the inflammatory response measured in the nose to that measured in the blood.\n\nParticipants will have two study visits including a blood draw, several nasal samplings (nasal lining fluid and nasal cells) and a saliva sampling, one within 72 hours of their hospital admission and another one month later. Nasal lining fluid and saliva will be obtained every two or three days until discharge from the hospital or resolution of symptoms. During those visits, questions regarding symptoms will be asked.",[75,23,76],"Pneumococcal Infections","Influenza Infection","RECRUITING","2025-05-21",{"date":80,"type":52},"2025-05-31",{"date":82,"type":52},"2024-12-03",{"date":84,"type":19},"2026-11",{"name":86,"class":87},"University Hospital, Geneva","OTHER"]